Experimental group:Jiexingjunzi granules

2 trials

Sponsors

Beijing University of Chinese Medicine Third Affiliated Hospital

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Early Phase 1

Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19)

Active, not recruitingITMCTR2000003243

Beijing University of Chinese Medicine Third Affiliated HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-05-01Updated: 2023-02-20

Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19)

Active, not recruitingChiCTR2000032313

Beijing University of Chinese Medicine Third Affiliated HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-05-01Updated: 2020-04-27